2020
Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis
KRAJICKOVA, Dagmar; Jiří KRÁL; Roman HERZIG; L'udovit KLZO; Antonin KRAJINA et al.Základní údaje
Originální název
Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis
Autoři
KRAJICKOVA, Dagmar; Jiří KRÁL; Roman HERZIG; L'udovit KLZO; Antonin KRAJINA; Jaroslav HAVELKA; Libor SIMUNEK; Oldrich VYSATA; Tran Van QUANG; Michal BAR a Martin VALIS
Vydání
Scientific Reports, USA, NATURE RESEARCH, 2020, 2045-2322
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30103 Neurosciences
Stát vydavatele
Německo
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.380
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/20:00118096
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
cerebral venous sinus thrombosis
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 2. 2. 2021 10:36, Mgr. Tereza Miškechová
Anotace
V originále
We aimed was to assess the factors influencing therapy choice and clinical outcome after 3-4 months in patients with cerebral venous sinus thrombosis (CVST). In a retrospective, bi-centric study, the set consisted of 82 consecutive CVST patients (61 females; mean age 33.5 +/- 15.7 years). Following data were collected: baseline characteristics, presence of gender-specific risk factors (GSRF), location and extent of venous sinus impairment, clinical presentation, type of treatment, recanalization, presence of parenchymal lesions, and clinical outcome after 3-4 months (assessed using the modified Rankin Scale [mRS], with excellent outcome defined as mRS 0-1). Multivariate logistic regression analysis was used for statistical evaluation. After 3-4 months, complete recovery was achieved in 41 (50%) and excellent clinical outcome in 67 (81.7%) patients. Female sex (OR 0.11; p=0.0189) and presence of focal neurologic deficit (OR 0.16; p=0.0165) were identified as significant independent negative predictors and, the presence of GSRF (OR 15.63; p=0.0011) as significant independent positive predictor of excellent clinical outcome. In conclusion, in our CVST patients, the presence of GSRF was associated with excellent clinical outcome, while the female sex itself was associated with poorer clinical outcome.